Sign in

You're signed outSign in or to get full access.

NASDAQ (NDAQ)

--

Earnings summaries and quarterly performance for NASDAQ.

Research analysts who have asked questions during NASDAQ earnings calls.

Alexander Blostein

Alexander Blostein

Goldman Sachs

6 questions for NDAQ

Also covers: AB, AMG, AMP +31 more
Ashish Sabadra

Ashish Sabadra

RBC Capital Markets

5 questions for NDAQ

Also covers: ADP, CBOE, CLVT +20 more
Benjamin Budish

Benjamin Budish

Barclays PLC

5 questions for NDAQ

Also covers: AB, APO, ARES +23 more
Brian Bedell

Brian Bedell

Deutsche Bank

5 questions for NDAQ

Also covers: AMG, AMTD, APO +22 more
Michael Cyprys

Michael Cyprys

Morgan Stanley

5 questions for NDAQ

Also covers: AAMI, AMP, AMTD +30 more
OL

Owen Lau

Oppenheimer & Co. Inc.

5 questions for NDAQ

Also covers: CLVT, CME, COIN +8 more
AK

Alex Kramm

UBS Group AG

4 questions for NDAQ

Also covers: BR, CBOE, CBRE +15 more
PM

Patrick Moley

Piper Sandler & Co.

4 questions for NDAQ

Also covers: BGC, CBOE, CME +17 more
Craig Siegenthaler

Craig Siegenthaler

Bank of America

3 questions for NDAQ

Also covers: AB, AMP, AMTD +26 more
DF

Dan Fannon

Jefferies & Company Inc.

3 questions for NDAQ

Also covers: AB, AMG, AMTD +22 more
DF

Daniel Fannon

Jefferies Financial Group Inc.

3 questions for NDAQ

Also covers: AB, AMG, AMTD +27 more
JS

Jeff Schmitt

William Blair & Company, L.L.C.

3 questions for NDAQ

Also covers: AIZ, AMP, FRGE +8 more
Kyle Voigt

Kyle Voigt

Keefe, Bruyette & Woods

3 questions for NDAQ

Also covers: AMTD, APO, ARES +17 more
MC

Michael Cho

JPMorgan Chase & Co.

3 questions for NDAQ

Also covers: ENV, FHI, FRGE +3 more
EA

Eli Abboud

Bank of America

2 questions for NDAQ

Also covers: BGC, CBOE, CME +2 more
SC

Simon Clinch

Redburn Atlantic

2 questions for NDAQ

Also covers: CME, EFX, FICO +4 more
WK

William Katz

TD Cowen

2 questions for NDAQ

Also covers: AB, AMG, AMTD +25 more
YC

Y. Cho

JPMorgan Chase & Co.

2 questions for NDAQ

Also covers: LPLA
AK

Alexander Kramm

UBS Group AG

1 question for NDAQ

Ben Budish

Ben Budish

Barclays PLC

1 question for NDAQ

Also covers: AB, APO, ARES +19 more
Brian Bertram Bedell

Brian Bertram Bedell

Deutsche Bank AG

1 question for NDAQ

CA

Christopher Allen

Citigroup

1 question for NDAQ

Also covers: CBOE, CME, ETOR +9 more
JS

Jeffrey Schmitt

William Blair

1 question for NDAQ

Also covers: AIZ, AMP, CBOE +8 more
KS

Kwun Sum Lau

Oppenheimer

1 question for NDAQ

Also covers: CBOE, CLVT, CME +9 more
SA

Simon Alistair Clinch

Redburn Atlantic

1 question for NDAQ

Also covers: CME, EFX, FICO +3 more

Recent press releases and 8-K filings for NDAQ.

Interactive Brokers clients outperform S&P 500 in 2025
NDAQ
  • In 2025, IBKR retail clients returned 19.20% vs 17.9% for the S&P 500, while IBKR hedge fund clients achieved 28.91%, outperforming the index by approximately 11 points.
  • Clients earned up to 3.14% on uninvested cash balances and margin rates as low as 4.14%, up to 55% below industry averages, enhancing net returns.
  • The platform offers access to more than 160 international markets, enabling diversified exposure across regions and asset classes.
  • Professional-grade execution tools, including sophisticated order types and smart routing, support efficient trade execution and risk management.
4 hours ago
Profusa adds French distributor MedSell to EU commercial network
NDAQ
Product Launch
  • Profusa partners with French distributor MedSell to commercialize its Lumee Oxygen tissue monitoring in hospitals and outpatient wound care clinics across France.
  • The new agreement expands Profusa’s existing network in Spain, Germany, the Benelux, Austria, the UK, and Scandinavia, collectively addressing approximately 200,000 annual CLI cases in the EU.
  • This distribution deal complements Profusa’s collaboration with Prof. Yann Gouëffic at Groupe Hospitalier Paris Saint Joseph, covering about 8% of France’s CLTI cases.
2 days ago
Snail Inc. reports strong year-end engagement, outlines content roadmap for 2026
NDAQ
Product Launch
New Projects/Investments
Revenue Acceleration/Inflection
  • Record user engagement in Q4 2025: Steam peak concurrent users hit 12,800 for the Maiden Voyage update, Bellwright sold over 150,000 units, ARK: Ultimate Mobile Edition surpassed 1,000,000 downloads, and the Survival Ascension DLC peaked at 46,900 CCU.
  • Multi-year content roadmap announced: detailed ARK releases through 2027, including titles such as FF: Survival Ascension, Bob’s True Tales: Tides of Fortune, ARK: World Creator, ARK: Atlantis and ARK: Legacy of Santiago Part 1.
  • Digital payment and tokenization initiatives: launched the USDO stablecoin and introduced the "Golden Poop" collectible token to explore new community-driven payment solutions.
3 days ago
BullFrog AI Publishes Annual Letter to Shareholders
NDAQ
Product Launch
  • BullFrog AI highlighted a commercial collaboration with Sygnature Discovery initiated in Q2 2025, expected to generate significant revenue through 2028.
  • The company launched BullFrog Data Networks™, an enterprise-grade AI platform, and bfPREP™, its AI-powered data preparation module, to accelerate adoption in drug development workflows.
  • It demonstrated real-world validation in a Phase 3 oncology program with Eleison Pharmaceuticals; results will be publicly presented at ASCO in January 2026.
  • BullFrog AI maintained capital discipline with an annual burn of approximately $6.2 million, plus a $10 million equity line and ATM, supporting runway and 2026 growth catalysts.
3 days ago
OBOOK Holdings reports H1 2025 results and completes infrastructure transition
NDAQ
Earnings
  • Core payment infrastructure is largely in place, positioning the company for enterprise-scale stablecoin activation beginning in 2026 while legacy businesses continue to provide stability.
  • Total revenue reached US$3.84 million in the first half of 2025, up from US$3.61 million a year earlier; payment services revenue rose 16% to US$2.17 million, and OwlNest revenue grew ~20%.
  • Gross profit was US$480 thousand (12.5% margin) versus US$540 thousand (15.0% margin) in H1 2024, reflecting a shift toward traditional payment channels.
  • Operating expenses totaled US$6.79 million, driven by one-time listing‐related costs; the net loss narrowed to US$3.91 million from US$5.35 million in H1 2024.
  • Operating cash outflows improved to US$1.29 million, down from US$4.45 million in the prior‐year period, reflecting stronger revenue and cost efficiencies.
4 days ago
Nasdaq Market Pulse Highlights AI Platform Launches and M&A Chatter
NDAQ
Product Launch
M&A
New Projects/Investments
  • Xeriant’s Factor X Research Group aims to accelerate innovations in green construction (projected at $1.8 trillion by 2030) and post-quantum cryptography (39.21% CAGR to $4.6 billion by 2030) through a Skunk Works-style R&D hub.
  • Society Pass launches TMG Social, a live commerce platform in Thailand targeting Southeast Asia’s $90 billion social commerce market, leveraging a 10,000+ influencer network and aiming for $10 million in 2026 revenue.
  • Adlai Nortye enters an exclusive Greater China licensing deal for its pan-RAS inhibitor AN9025, with total consideration of up to RMB 1.6 billion (~$230 million), including over $20 million in upfront and near-term milestones.
  • SoftBank is exploring a potential acquisition of DigitalBridge, which manages over $100 billion in digital infrastructure assets across data centers, fiber, towers, and edge networks.
  • Brand Engagement Network secures a custom AI engagement project for a top-10 global pharma, expecting $250,000 in Q4 2025 development revenue and recurring license fees beginning in Q1 2026.
4 days ago
IP Strategy cancels $15M equity line to reinforce balance sheet
NDAQ
  • Terminated its open $15 million Equity Line of Credit effective December 22, 2025, with no further purchases or puts executed.
  • Move is intended to avoid further shareholder dilution and underscore the company’s strong balance sheet focus.
  • As of year-end 2025, IP Strategy holds 53.2 million $IP tokens as a primary reserve asset.
4 days ago
ARS Pharmaceuticals announces neffy® approval in China
NDAQ
Product Launch
  • The National Medical Products Administration approved neffy® 2 mg nasal spray for emergency treatment of Type I allergic reactions (anaphylaxis) in adults and children ≥30 kg, marking it as the first community use epinephrine product in China; availability expected spring 2026.
  • Under a 2021 exclusive license, ARS Pharma will supply neffy to Pediatrix Therapeutics at cost and receive a $4 million regulatory milestone plus up to $80 million in sales milestones and low-double-digit royalties.
  • An estimated 50–100 million people in China are at risk for severe food allergies and anaphylaxis, highlighting a substantial unmet need for accessible epinephrine treatment outside hospital settings.
4 days ago
REE Automotive signs MOU with Cascadia Motion for REEcorner-based EDUs
NDAQ
Product Launch
New Projects/Investments
  • REE Automotive entered a non-binding MOU with BorgWarner’s Cascadia Motion to co-develop and supply next-generation electric drive units (EDUs) that integrate REEcorner technology with the iM-125 inverter-motor module, under a royalty-bearing, time-limited exclusive distribution option and access to REE’s assembly line and tooling.
  • The partnership builds on a three-year collaboration to accelerate global OEM electrification programs with compact, cross-platform EDUs designed for ASIL-D functional safety and secure OTA updates.
  • Global EDU market is forecast to grow at a 9% CAGR from 2025 to 2035 and double in size by 2035, according to industry estimates.
  • Combined EDU performance: 3000 Nm peak torque, 100 kW peak power, 2150 Nm continuous torque, and 54 kg weight, delivered via a 400 V permanent-magnet motor in a 19.17:1 gear ratio.
4 days ago
Caterpillar leads Dow with 61% YTD surge
NDAQ
  • Caterpillar has surged 61% YTD, becoming the Dow’s top performer as it pivots toward power-generation and AI-adjacent businesses.
  • Average analyst price target implies about 1% upside, with CFRA analysts warning of “sky-high” expectations and stretched valuations.
  • NXP Semiconductors and Deckers highlighted for weakening fundamentals, including sales declines, shrinking free-cash-flow margins, and below-industry operating margins.
  • Israel’s TA-125 index is up 52% YTD, driven mainly by domestic retail buying, with turnover up over 50% and sector returns led by insurance, banks, and energy-infrastructure stocks.
  • Promotional AI-energy pitches stress extreme energy consumption claims and position power and nuclear asset owners as “backdoor” AI plays.
5 days ago